These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12566753)

  • 1. Comparison of the clinical efficacy and safety of flutamide versus flutamide plus an oral contraceptive in the treatment of hirsutism.
    Taner C; Inal M; Başogul O; Onoglu A; Karanfil C; Tinar S; Ispahi C
    Gynecol Obstet Invest; 2002; 54(2):105-8. PubMed ID: 12566753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacy of low dose flutamide plus Diane-35 in the treatment of idiopathic hirsutism and polycystic ovary syndrome.
    Boztosun A; Açmaz G; Ozturk A; Müderris II
    Ginekol Pol; 2013 Apr; 84(4):258-62. PubMed ID: 23700857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the clinical efficacy of flutamide and spironolactone plus Diane 35 in the treatment of idiopathic hirsutism: a randomized controlled study.
    Inal MM; Yildirim Y; Taner CE
    Fertil Steril; 2005 Dec; 84(6):1693-7. PubMed ID: 16359967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
    De Leo V; Fulghesu AM; la Marca A; Morgante G; Pasqui L; Talluri B; Torricelli M; Caruso A
    Gynecol Endocrinol; 2000 Dec; 14(6):411-6. PubMed ID: 11228061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism.
    Dodin S; Faure N; Cédrin I; Méchain C; Turcot-Lemay L; Guy J; Lemay A
    Clin Endocrinol (Oxf); 1995 Nov; 43(5):575-82. PubMed ID: 8548942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
    Sahin Y; Dilber S; Keleştimur F
    Fertil Steril; 2001 Mar; 75(3):496-500. PubMed ID: 11239530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism.
    Pazos F; Escobar-Morreale HF; Balsa J; Sancho JM; Varela C
    Fertil Steril; 1999 Jan; 71(1):122-8. PubMed ID: 9935128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism.
    Erenus M; Gürbüz O; Durmuşoğlu F; Demirçay Z; Pekin S
    Fertil Steril; 1994 Apr; 61(4):613-6. PubMed ID: 8150100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Venturoli S; Marescalchi O; Colombo FM; Macrelli S; Ravaioli B; Bagnoli A; Paradisi R; Flamigni C
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1304-10. PubMed ID: 10199771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of flutamide and cyproterone acetate in the treatment of hirsutism: a randomized controlled trial.
    Grigoriou O; Papadias C; Konidaris S; Antoniou G; Karakitsos P; Giannikos L
    Gynecol Endocrinol; 1996 Apr; 10(2):119-23. PubMed ID: 8701785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effectiveness of flutamide alone or combined with oral contraceptives in the treatment of hirsutism in women].
    Devoto E; Aravena L
    Rev Med Chil; 2004 Jul; 132(7):845-52. PubMed ID: 15379332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients.
    Ciotta L; Cianci A; Marletta E; Pisana L; Aglianò A; Palumbo G
    Fertil Steril; 1994 Dec; 62(6):1129-35. PubMed ID: 7957975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenisms.
    Acién P; Mauri M; Gutierrez M
    Hum Reprod; 1997 Mar; 12(3):423-9. PubMed ID: 9130733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism.
    Müderris II; Bayram F
    J Endocrinol Invest; 1999 Mar; 22(3):165-8. PubMed ID: 10219882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of spironolactone-oral contraceptive versus cyproterone acetate-estrogen regimens in the treatment of hirsutism.
    Erenus M; Yücelten D; Gürbüz O; Durmuşoğlu F; Pekin S
    Fertil Steril; 1996 Aug; 66(2):216-9. PubMed ID: 8690104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence rate of hirsutism after 3 different antiandrogen therapies.
    Yücelten D; Erenus M; Gürbüz O; Durmuşoğlu F
    J Am Acad Dermatol; 1999 Jul; 41(1):64-8. PubMed ID: 10411413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and tolerability of flutamide for the treatment of hirsutism.
    Castelo-Branco C; Moyano D; Gómez O; Balasch J
    Fertil Steril; 2009 Apr; 91(4):1183-8. PubMed ID: 18339379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism.
    Dikensoy E; Balat O; Pence S; Akcali C; Cicek H
    Arch Gynecol Obstet; 2009 Mar; 279(3):321-7. PubMed ID: 18607612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
    Carr BR; Breslau NA; Givens C; Byrd W; Barnett-Hamm C; Marshburn PB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.